Aditxt, INC Form 4 insider transactions

Takeover Time 2026 LLC, a 10% owner and director of Aditxt, Inc., reported the acquisition of 3,420,439 shares of common stock on June 23, 2026.

HRT Financial LP reports significant transactions in Aditxt, Inc. common stock, including acquisitions and dispositions.

Tai Wey Ann updates beneficial ownership filing for Aditxt, Inc. (ADTX) due to updated outstanding share count.

HRT Financial LP has reported a significant change in its beneficial ownership of Aditxt, Inc. Class A Shares.

DRW Securities, LLC, a 10% owner, has reported a transaction involving common stock of Aditxt, Inc. (ADTX).

HRT Financial LP reported significant transactions involving Aditxt, Inc. common stock, including the acquisition and disposal of shares.

HRT Financial LP reported significant transactions in Aditxt, Inc. common stock, including the acquisition of over 4.2 million shares.

Bank of America Corporation reports minor changes in beneficial ownership of Aditxt, Inc. common stock.

HRT Financial LP reported the sale of 2,833,463 shares of Aditxt, Inc. common stock at a price of $0.014 per share.

HRT Financial LP reports significant transactions in Aditxt, Inc. common stock, including acquisitions and dispositions.

Major shareholders Sandie Gong and Devon Xin Xu have sold their entire 100,000-share stake in Aditxt, Inc., exiting their position in the company.

HRT Financial LP has fully liquidated its holdings in Aditxt, Inc. following a series of transactions in June 2026.

HRT FINANCIAL LP, a 10% owner and director of Aditxt, Inc., reported significant transactions involving Class A Shares.

HRT Financial LP reports transactions involving Aditxt, Inc. Class A Shares, including acquisitions and dispositions.

Aditxt Director Brian Michael Brady sold one share of common stock for $1.75 on December 17, 2025, citing tax-related purposes.

Aditxt's Chief M&A Officer, Corinne Pankovcin, reported the sale of one common stock share for tax-related reasons.

HRT Financial LP, a 10% owner of Aditxt, Inc., reports the acquisition and subsequent disposal of Class A shares within a two-day period.

Aditxt, Inc. and Evofem Biosciences, Inc. have amended their merger agreement for the second time, adjusting the schedule and amounts for Aditxt's equity investments in Evofem.

Aditxt and Evofem amend their merger agreement, targeting a September 30 closing, while Evofem acquires SOLOSEC to expand its women's health portfolio.

Aditxt, Adicure, and Evofem Biosciences have entered into a third amendment to their merger agreement, modifying the terms of the equity investment and extending the timeline for filing the joint proxy statement.